Study for people with Breast Cancer
Not yet recruiting Not a phased study
This trial at a glance
Where this trial is running
| Site | City | State or country | Status at this site |
|---|---|---|---|
| Chris O'Brien Lifehouse | Camperdown | NSW | Status not stated |
| Mater Hospital Sydney | Sydney | NSW | Status not stated |
| Lyell McEwin Hospital | Adelaide | SA | Status not stated |
| Icon Cancer Centre | Hobart | TAS | Status not stated |
| Eastern Health | Box Hill | VIC | Status not stated |
| Monash Health | Clayton | VIC | Status not stated |
| Peter MacCallum Cancer Centre | Melbourne | VIC | Status not stated |
| Royal Melbourne Hospital | Melbourne | VIC | Status not stated |
| Sir Charles Gairdner Hospital | Nedlands | WA | Status not stated |
voxsanity.com.au · trial sites from public registries · registry record synced 11 October 2026 · not medical advice
Who can join
The official eligibility criteria
Registry text, reproduced exactly. These are the words the trial's sponsor published on ClinicalTrials.gov. They have not been edited, shortened or rewritten, and they are written for researchers rather than for patients.
Inclusion Criteria:
1. Patient has provided written informed consent using the FERTILE Patient Information and Consent form (PICF)
2. Early-stage TNBC (definition determined as per clinicians' discretion)
3. Female patients between 18 and 42 years of age
4. Planned to receive at least one dose of neoadjuvant chemotherapy-ICI with a PD-(L)1 inhibitor including but not limited to pembrolizumab, atezolizumab, durvalumab or nivolumab
5. Planned to receive gonadotrophin releasing hormone (GnRH) agonist with neoadjuvant chemotherapy
Exclusion Criteria:
1. Previous removal of both ovaries or ovarian ablation (such as bilateral ovarian radiotherapy)
2. Patients who have previously received immunotherapy or chemotherapy prior to registration
3. Receiving or planned to receive adjuvant endocrine therapy Note: patients using GnRH agonist for POI prevention are not excluded
4. Post-menopausal as defined by the investigator
5. Presence of any psychological, social, geographical, or other condition for which, in the opinion of the site Investigator, participation would not be in the best interest of the patient (e.g., compromise the well-being) or that could prevent, limit, or confound the protocol-specified assessments
Dates on the record
Results, publications and the official record
- No results are posted on the official record yet.
- No publications are listed on the official record yet.
- Official record and contacts on ClinicalTrials.gov – contact details for each site are kept there, and are not copied onto this page.
Sources and dates
- ClinicalTrials.gov – the record this page reformats
- ClinicalTrials.gov processing date: 14 April 2026.
- This page last checked by Voxsanity: 11 October 2026.
Voxsanity reformats data from public registries into this layout. It does not edit, interpret or add to what the registry published.
Not medical advice.
Individual trial records are refreshed on a rolling basis rather than all at once, so a record may be up to several weeks old. Each trial page and trial card shows the date its own record was last synced. Where a record has lagged, its status, sites and enrolment can differ from the current registry state in either direction, so check the registry link on the trial page before acting on them.
Letter for your doctor
A one-page summary of this trial to print or email to your GP. It carries the registry's own record of the trial and its eligibility criteria, and nothing Voxsanity has written about whether it suits you.